Peter K. Vogt

Q: What Schools Are Affiliated With Peter K. Vogt

Peter K. Vogt is affiliated with the following schools: University of East Anglia, University of Oxford, California Institute of Technology, University of Tokyo, University of Southern California, Kyoto University, University of Helsinki, Monash University, University College London, University of Colorado Denver, Stanford University, Case Western Reserve University, University of Tübingen, University of Washington, University of Würzburg, University of Ferrara

Peter K. Vogt's AcademicInfluence.com Rankings

Peter K. Vogt

Biology

#740

World Rank

#1285

Historical Rank

#404

USA Rank

Molecular Biology

#158

World Rank

#162

Historical Rank

#82

USA Rank

Genetics

#192

World Rank

#236

Historical Rank

#103

USA Rank

biology Degrees

Download Badge

Biology

Peter K. Vogt's Degrees

PhD Molecular Biology Stanford University

Why Is Peter K. Vogt Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes. Education and academic appointments Vogt received his undergraduate education in biology at the University of Würzburg and in 1959 was awarded his Ph.D. at the University of Tübingen for work done at the Max Planck Institute for Virology in Tübingen. From 1959 to 1962 he was Damon Runyon Cancer Research Fellow in the laboratory of Harry Rubin at the University of California in Berkeley and started to work on Rous sarcoma virus. He taught microbiology and molecular biology to medical and graduate students at the University of Colorado in Denver and the University of Washington in Seattle . In 1971, he joined the University of Southern California as Hastings Professor of Microbiology and in 1980 assumed the chairmanship of the Department of Microbiology at the School of Medicine. Since 1993, he has been a professor at The Scripps Research Institute in La Jolla. He served as senior vice president for scientific affairs at Scripps from 2012 to 2015.

(See a Problem?)

Peter K. Vogt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA (1976) (1283)
Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. (1987) (1145)
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. (2005) (816)
Oncogenic PI3K deregulates transcription and translation (2005) (761)
Class I PI3K in oncogenic cellular transformation (2008) (572)
Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. (2001) (556)
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. (2000) (542)
Fos-associated protein p39 is the product of the jun proto-oncogene. (1988) (542)
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. (1997) (427)
Cancer-specific mutations in PIK3CA are oncogenic in vivo (2006) (420)
Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanisms (2008) (411)
The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. (1998) (403)
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail (1977) (399)
Avian sarcoma virus 17 carries the jun oncogene. (1987) (388)
Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt (2009) (368)
Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. (1969) (354)
Rare cancer-specific mutations in PIK3CA show gain of function (2007) (353)
Human immunodeficiency viruses. (1986) (346)
A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. (2001) (323)
jun: oncogene and transcription factor. (1990) (319)
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts (2002) (301)
Triple Layer Control: Phosphorylation, Acetylation and Ubiquitination of FOXO Proteins (2005) (301)
Jun, the oncoprotein (2001) (296)
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites (1978) (294)
The akt kinase: molecular determinants of oncogenicity. (1998) (291)
MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer (2014) (273)
What to call the AIDS virus? (1986) (262)
Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. (1999) (249)
Induction of avian tumor viruses in normal cells by physical and chemical carcinogens. (1971) (244)
Differences between the Ribonucleic Acids of Transforming and Nontransforming Avian Tumor Viruses* (1970) (244)
Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase (2006) (241)
Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses. (1973) (235)
Characteristics of two new avian tumor virus subgroups. (1969) (230)
Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation (1989) (224)
Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens. (1965) (223)
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling (2016) (222)
Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. (1987) (214)
Defectiveness of avian myelocytomatosis virus MC29: isolation of long-term nonproducer cultures and analysis of virus-specific polypeptide synthesis. (1977) (212)
Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. (2004) (210)
Genetics of RNA Tumor Viruses (1977) (199)
Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end (1975) (197)
Spontaneous segregation of nontransforming viruses from cloned sarcoma viruses. (1971) (195)
An avian leukosis virus related to RSV(O): properties and evidence for helper activity. (1971) (193)
Patterns of viral interference in the avian leukosis and sarcoma complex. (1966) (192)
Gel Electrophoresis of Avian Leukosis and Sarcoma Viral RNA in Formamide: Comparison with Other Viral and Cellular RNA Species (1973) (191)
Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. (2006) (185)
Proposal for Naming Host Cell-Derived Inserts in Retrovirus Genomes (1981) (183)
Immunological relationships among envelope antigens of avian tumor viruses. (1966) (179)
Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. (1999) (176)
tsRNA signatures in cancer (2017) (176)
Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. (1990) (166)
Temperature sensitive mutants of an avian sarcoma virus. (1969) (160)
Cyclin Dependent Kinase (2011) (158)
An avian leukosis virus associated with stocks of Rous sarcoma virus. (1962) (156)
v-jun encodes a nuclear protein with enhancer binding properties of AP-1 (1988) (155)
Therapeutic Targeting of Myc. (2010) (148)
Glycoprotein components of avian and murine RNA tumor viruses. (1970) (147)
Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo (2006) (147)
PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity (2011) (144)
Cancer-specific mutations in phosphatidylinositol 3-kinase. (2007) (141)
Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α (2010) (140)
Avian tumor viruses. (1965) (134)
Genetically stable reassortment of markers during mixed infection with avian tumor viruses. (1971) (132)
PI 3-kinase, mTOR, protein synthesis and cancer. (2001) (131)
An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. (1998) (130)
Phosphorylation of AKT: a Mutational Analysis (2011) (130)
Fortuitous convergences: the beginnings of JUN (2002) (128)
High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures (1978) (124)
Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions. (2009) (124)
The RNA of avian acute leukemia virus MC29. (1977) (124)
The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. (1996) (124)
Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts (1973) (120)
Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase. (2000) (120)
RNA species obtained from clonal lines of avian sarcoma and from avian leukosis virus. (1973) (120)
Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice (1990) (119)
Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence (2012) (118)
A vegetation map of South America (2002) (116)
Evidence for crossing-over between avian tumor viruses based on analysis of viral RNAs. (1974) (112)
Oncogenic transformation induced by membrane-targeted Akt2 and Akt3 (2001) (111)
The retroviral oncogene qin belongs to the transcription factor family that includes the homeotic gene fork head. (1993) (110)
Phosphatidylinositol 3-kinase: the oncoprotein. (2010) (109)
A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth (2007) (109)
Oncogenic signaling of class I PI3K isoforms (2008) (108)
Transformation by rous sarcoma virus: effects on cellular glycolipids. (1971) (106)
Inhibitor of MYC identified in a Kröhnke pyridine library (2014) (105)
Appearance of virus-specific DNA in mammalian cells following transformation by Rous sarcoma virus. (1973) (104)
PI3K and STAT3: a new alliance. (2011) (104)
Historical Introduction to the General Properties of Retroviruses (1997) (104)
Localization of avian tumor virus group-specific antigen in cell and virus. (1966) (102)
A Jun-binding protein related to a putative tumor suppressor. (1993) (101)
Genome-scale functional profiling of the mammalian AP-1 signaling pathway (2003) (100)
Hot-spot mutations in p110α of phosphatidylinositol 3-kinase (PI3K): Differential interactions with the regulatory subunit p85 and with RAS (2010) (99)
Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. (1999) (97)
The oncogene jun and nuclear signalling. (1989) (95)
Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent. (1992) (94)
Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: evidence for a second class of transforming genes. (1979) (94)
100 years of Rous sarcoma virus (2011) (93)
Quantification of nascent transcription by bromouridine immunocapture nuclear run-on RT-qPCR (2015) (90)
Reversion from transformed to normal phenotype by inhibition of protein synthesis in rat kidney cells infected with a temperature-sensitive mutant of Rous sarcoma virus. (1976) (89)
A credit-card library approach for disrupting protein-protein interactions. (2006) (87)
DEAE-dextran: enhancement of cellular transformation induced by avian sarcoma viruses. (1967) (86)
Inhibition of Protein Synthesis by Y Box-Binding Protein 1 Blocks Oncogenic Cell Transformation (2005) (86)
PI3K: from the bench to the clinic and back. (2010) (85)
The Catalytic Subunit of Phosphoinositide 3-Kinase: Requirements for Oncogenicity* (2000) (85)
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. (1973) (83)
PI 3-kinase and cancer: changing accents. (2009) (82)
Phenotypic mixing in the avian tumor virus group. (1967) (82)
A HETEROGENEITY OF ROUS SARCOMA VIRUS REVEALED BY SELECTIVELY RESISTANT CHICK EMBRYO CELLS. (1965) (78)
The defectiveness of Mill Hill 2, a carcinoma-inducing avian oncovirus. (1978) (77)
The cell cycle-dependent nuclear import of v-Jun is regulated by phosphorylation of a serine adjacent to the nuclear localization signal (1995) (77)
RNA tumor viruses of pheasants: characterization of avian leukosis subgroups F and G. (1974) (76)
Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). (2004) (76)
A virus released by "nonproducing" Rous sarcoma cells. (1967) (75)
MYC regulates the non-coding transcriptome (2014) (73)
Avian erythroblastosis virus: transformation-specific sequences form a contiguous segment of 3.25 kb located in the middle of the 6-kb genome. (1979) (72)
Properties of mammalian cells transformed by temperature-sensitive mutants of avian sarcoma virus (1977) (70)
Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein (1996) (70)
Conditional lethal mutants of avian sarcoma viruses. I. Physiology of ts 75 and ts 149. (1971) (70)
The avian cellular homolog of the oncogene jun. (1988) (68)
Localization of infectious virus and viral antigen in chick fibroblasts during successive stages of infection with Rous sarcoma virus. (1961) (68)
Essential role of Stat3 in PI3K-induced oncogenic transformation (2011) (67)
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway (2003) (67)
Oncogenicity of avian leukosis viruses of different subgroups and of mutants of sarcoma viruses (1977) (66)
RNA of replication-defective strains of Rous sarcoma virus. (1975) (66)
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. (1981) (66)
Human T-Cell Leukemia Virus (1985) (64)
Constitutively active Rheb induces oncogenic transformation (2008) (64)
The oncogene qin codes for a transcriptional repressor. (1995) (63)
The butterfly effect in cancer: A single base mutation can remodel the cell (2015) (63)
Design, synthesis, and validation of a β-turn mimetic library targeting protein-protein and peptide-receptor interactions. (2011) (63)
Phosphorylation by Akt disables the anti-oncogenic activity of YB-1 (2008) (62)
Effects of genetic cellular resistance on cell transformation and virus replication in chicken hematopoietic cell cultures infected with avian myeloblastosis virus (BAI-A). (1968) (61)
The genetic structure of RNA tumor viruses. (1977) (60)
The reproductive and cell-transforming capacities of avian sarcoma virus B77: inactivation with UV light. (1970) (60)
Cell-free translation of avian erythroblastosis virus RNA yields two specific and distinct proteins with molecular weights of 75,000 and 40,000. (1980) (60)
An avian sarcoma virus mutant that is temperature sensitive for virion assembly. (1976) (59)
Requirement of Phosphatidylinositol(3,4,5)Trisphosphate in Phosphatidylinositol 3-Kinase-Induced Oncogenic Transformation (2009) (57)
The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family. (1989) (57)
Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRβ/B-RAF (2010) (56)
Long antisense non-coding RNAs and their role in transcription and oncogenesis (2010) (56)
Determination of the defective function in two mutants of Rous sarcoma virus. (1974) (55)
Control of erythroid differentiation: asynchronous expression of the anion transporter and the peripheral components of the membrane skeleton in AEV- and S13-transformed cells (1986) (53)
Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysis. (2005) (53)
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses (1981) (52)
Characterization of a 105,000 molecular weight gag-related phosphoprotein from cells transformed by the defective avian sarcoma virus PRCII. (1981) (51)
Mutated PI 3-Kinases: Cancer Targets on a Silver Platter (2005) (51)
Excess FoxG1 causes overgrowth of the neural tube. (2003) (51)
RNA tumor virus specific sequences in nuclear DNA of several avian species. (1975) (51)
Localization of the human JUN protooncogene to chromosome region 1p31-32. (1988) (51)
Mapping oligonucleotides of Rous sarcoma virus RNA that segregate with polymerase and group-specific antigen markers in recombinants. (1976) (50)
The oncogenic potential of the high mobility group box protein Sox3. (2000) (50)
Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation. (2009) (49)
Isolation of three new avian sarcoma viruses: ASV 9, ASV 17, and ASV 25. (1985) (48)
Stabilizers of the Max Homodimer Identified in Virtual Ligand Screening Inhibit Myc Function (2009) (48)
Malaria: Drugs, Disease and Post-genomic Biology (2005) (47)
Avian RNA tumor viruses: mechanism of recombination and complexity of the genome. (1975) (47)
MafA has strong cell transforming ability but is a weak transactivator (2003) (47)
Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. (1979) (46)
Electron microscope studies of tumor virus RNA. (1975) (46)
Cell entry by non-enveloped viruses. (2010) (44)
Proposal for Numbering Mutants of Avian Leukosis and Sarcoma Viruses (1974) (44)
Nuclear factor I interferes with transformation induced by nuclear oncogenes. (1995) (43)
Studies on the assay and multiplication of avian myeloblastosis virus. (1963) (42)
The transformation-specific proteins of avian (Fujinami and PRC-II) and feline (Synder--Theilen and Gardner--Arnstein) sarcoma viruses are immunologically related. (1981) (42)
Phosphoinositide 3-kinase: from viral oncoprotein to drug target. (2006) (41)
Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation. (1992) (41)
Distribution of envelope-specific and sarcoma-specific nucleotide sequences from different parents in the RNAs of avian tumor virus recombinants. (1976) (41)
An essential role for protein synthesis in oncogenic cellular transformation (2004) (41)
Temperature-sensitive v-sea transformed erythroblasts: a model system to study gene expression during erythroid differentiation. (1988) (40)
Satellites and Defective Viral RNAs (1999) (40)
A third class of avian sarcoma viruses, defined by related transformation-specific proteins of Yamaguchi 73 and Esh sarcoma viruses. (1981) (39)
Human immunodeficiency viruses [letter] (1986) (39)
Restitution of fibroblast-transforming ability in src deletion mutants of avian sarcoma virus during animal passage. (1979) (39)
The pathogenicity and defectiveness of PRCII: A new type of avian sarcoma virus (1981) (39)
Oncogenic transformation induced by the Qin protein is correlated with transcriptional repression. (1997) (38)
The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity. (1985) (37)
Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosides. (2004) (37)
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. (1977) (36)
Jun inhibits myogenic differentiation. (1991) (36)
A downstream kinase of the mammalian target of rapamycin, p70S6K1, regulates human double minute 2 protein phosphorylation and stability (2006) (36)
A newly isolated avian sarcoma virus, ASV-1, carries the crk oncogene. (1989) (36)
Aberrant cell growth induced by avian winged helix proteins. (1997) (36)
Sequence-selective carbohydrate-DNA interaction: dimeric and monomeric forms of the calicheamicin oligosaccharide interfere with transcription factor function. (1996) (36)
S13, a rapidly oncogenic replication-defective avian retrovirus. (1985) (35)
Avian winged helix proteins CWH-1, CWH-2 and CWH-3 repress transcription from Qin binding sites (1997) (35)
Cyclin Dependent Kinase (CDK) Inhibitors (1998) (35)
Susceptibility and resistance of chicken macrophages to avian RNA tumor viruses. (1975) (35)
Esh avian sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein kinase activity. (1981) (34)
The genomic RNA of avian reticuloendotheliosis virus REV. (1980) (34)
Glycolipids of chick embryo fibroblasts infected with temperature-sensitive mutants of avian sarcoma viruses. (1977) (33)
Reversion of transformed glycolysis to normal by inhibition of protein synthesis in rat kidney cells infected with temperature-sensitive mutant of Rous sarcoma virus. (1978) (32)
Discovery of inhibitors of aberrant gene transcription from Libraries of DNA binding molecules: inhibition of LEF-1-mediated gene transcription and oncogenic transformation. (2009) (31)
Oncogenic transformation by β-catenin: deletion analysis and characterization of selected target genes (2002) (31)
Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K) (2014) (31)
Binding of the corepressor TLE1 to Qin enhances Qin-mediated transformation of chicken embryo fibroblasts (2003) (31)
Temperature-sensitive mutants of avian sarcoma viruses. Genetic recombination with wild type sarcoma virus and physiological analysis of multiple mutants. (1976) (30)
Synthesis, structure, and integration of the DNA of RNA tumor viruses. (1979) (30)
Interaction of cellular factors related to the Jun oncoprotein with the promoter of a replication-dependent hamster histone H3.2 gene. (1989) (30)
Avian cellular homolog of the qin oncogene. (1995) (30)
Electron Microscopy of Chick Fibroblasts Infected by Defective Rous Sarcoma Virus and Its Helper (1967) (30)
Characterization of the env gene in avian oncoviruses by heteroduplex mapping (1978) (29)
Avian retrovirus S13: properties of the genome and of the transformation-specific protein. (1985) (29)
Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription (2003) (29)
Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization. (2008) (29)
30 Dangerous Liaisons: Fos and Jun, Oncogenic Transcription Factors (1992) (28)
Genetic analysis of the defectiveness in strain MC29 avian leukosis virus. (1978) (28)
In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential (2014) (28)
Oncogenic transformation by Jun: role of transactivation and homodimerization. (1992) (28)
Integration of avian sarcoma virus DNA in chicken cells. (1981) (28)
Distribution of Tissue-Specific Antigens in Centrifugal Fractions of Rat Liver (1958) (28)
The terminal oligonucleotides of avian tumor virus RNAs are genetically linked. (1977) (27)
Identification and characterization of genes upregulated in cells transformed by v-Jun (2000) (27)
Presence of avian tumor virus group-specific antigen in nonproducing Rous sarcoma cells of the chicken. (1965) (27)
Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts (2001) (27)
Subgroup-specific antigenic determinants of avian RNA tumor virls structural proteins: analysis of virus recombinants. (1976) (27)
The chicken junD gene and its product. (1991) (27)
MYCNOS functions as an antisense RNA regulating MYCN (2015) (27)
Envelope Classification of Avian RNA Tumor Viruses1 (1970) (27)
c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic. (1992) (26)
Inhibition of avian sarcoma virus replication by glucosamine. (1974) (25)
Chromosomal Translocations and Oncogenic Transcription Factors (1997) (25)
Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication. (1993) (25)
Cytoskeletal organization, vinculin-phosphorylation, and fibronectin expression in transformed fibroblasts with different cell morphologies. (1986) (25)
An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation (2020) (25)
Evidence for three classes of avian sarcoma viruses: comparison of the transformation-specific proteins of PRCII, Y73, and Fujinami viruses. (1981) (25)
Conditional lethal mutants of avian sarcoma viruses. II. Analysis of the temperature-sensitive lesion in ts 75. (1971) (24)
v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity (2000) (23)
Progress in breast cancer research (2012) (23)
On the role of DNA synthesis in avian tumor virus infection. (1969) (23)
ProteinInferencer: Confident protein identification and multiple experiment comparison for large scale proteomics projects. (2015) (22)
PIK3CA Cooperates with KRAS to Promote MYC Activity and Tumorigenesis via the Bromodomain Protein BRD9 (2019) (22)
Characteristics of avian sarcoma virus strain PRCIV and comparison with strain PRCII-p. (1981) (22)
Differential and antagonistic effects of v-Jun and c-Jun. (1996) (22)
Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera. (1997) (22)
Bacterial Infection: Close Encounters at the Host Pathogen Interface (1998) (22)
Phosphoinositide 3-kinase in health and disease (2011) (22)
An Algorithm for Generating Small RNAs Capable of Epigenetically Modulating Transcriptional Gene Silencing and Activation in Human Cells (2013) (22)
The growth-promoting activity of the Bad protein in chicken embryo fibroblasts requires binding to protein 14-3-3 (2001) (22)
Non-Amide-Based Combinatorial Libraries Derived fromN-Boc-Iminodiacetic Acid: Solution-Phase Synthesis of Piperazinone Libraries with Activity Against LEF-1/β-Catenin-Mediated Transcription (2000) (22)
Avian oncovirus Mill Hill No. 2: pathogenicity in chickens. (1979) (22)
Phenotypic mixing between reticuloendotheliosis virus and avian sarcoma viruses. (1977) (22)
TOWARDS A COMPLETE GENETIC MAP OF ROUS SARCOMA VIRUS (1976) (22)
The cytology of Rous sarcoma virus infection. (1962) (21)
Inhibition of avian sarcoma virus replication by glucosamine: a specific effect on the synthesis and processing of viral proteins. (1976) (21)
Envelope classification of avian RNA tumor viruses. (1970) (21)
The emerging genetics of RNA tumor viruses. (1972) (21)
PI 3-Kinases: Hidden Potentials Revealed (2006) (20)
Observations on the surface of cells infected with Rous sarcoma virus. (1963) (20)
Revelations of a captive: retroviral Qin and the oncogenicity of winged helix proteins. (1997) (20)
The pathogenicity and defectiveness of PRCII: a new type of avian sarcoma virus. (1981) (20)
Retroviruses: strategies of replication. (1990) (20)
Endogenous leukosis viruses in the avian family Phasianidae. (1977) (19)
Kinase inhibitors: vice becomes virtue. (2006) (19)
Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications (2021) (19)
Glutaredoxin is a direct target of oncogenic jun (1998) (19)
Biological and biochemical studies on the inactivation of avian oncoviruses by ultraviolet irradiation. (1977) (18)
Recovered src genes are polymorphic and contain host markers. (1980) (18)
Cleavage of four avian sarcoma virus polyproteins with virion protease p15 removes gag sequences and yields large fragments that function as tyrosine phosphoacceptors in vitro. (1981) (18)
Efficient induction of fibrosarcomas by v-jun requires mutations in the DNA binding region and the transactivation domain. (1994) (18)
PI3K p110β: more tightly controlled or constitutively active? (2011) (18)
Domains of the qin protein required for oncogenic transformation. (1996) (18)
The Major Histocompatibility Antigens in Various Species (1970) (18)
Temperature-sensitive mutants of avian sarcoma viruses: genetic recombination between multiple or coordinate mutants and avian leukosis viruses. (1976) (17)
A Single‐Stranded DNA‐Encoded Chemical Library Based on a Stereoisomeric Scaffold Enables Ligand Discovery by Modular Assembly of Building Blocks (2020) (17)
Phosphatidylinositol 4,5‐bisphosphate‐specific AKT1 is oncogenic (2010) (17)
Normal-tissue effects of irradiation for Kaposi's sarcoma/AIDS. (1989) (17)
PI 3 K and STAT 3 : A New Alliance (2011) (17)
The carboxy terminus of the viral Jun oncoprotein is required for complex formation with the cellular Fos protein. (1989) (16)
Quantitation and Localization of Rous Sarcoma Virus-Specific RNA in Transformed and Revertant Field Vole Cells (1978) (16)
A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma. (1999) (16)
Transacting Functions of Human Retroviruses (1995) (16)
Endogenous proviruses of random-bred chickens and ring-necked pheasants: analysis with restriction endonucleases. (1981) (15)
Class II defective avian sarcoma viruses: comparative analysis of genome structure. (1982) (15)
Jun: stealth, stability, and transformation. (2005) (15)
A rearranged junD transforms chicken embryo fibroblasts. (1992) (15)
Understanding PLZF (2011) (14)
Wounding acts as a tumor promoter in chickens inoculated with avian sarcoma virus 17. (1992) (14)
Domain analysis reveals striking functional differences between the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), p85α and p85β (2017) (13)
Isoform-specific activities of the regulatory subunits of phosphatidylinositol 3-kinases – potentially novel therapeutic targets (2018) (13)
Jun: oncogene and transcriptional regulator. (1988) (13)
Retroviral oncogenes and TOR. (2004) (13)
Retroviral Insertion and Oncogene Activation (1991) (13)
A Mutant of Rous Sarcoma Virus (Type O) Causing Fusiform Cell Transformation 1 (1970) (13)
The new serine-threonine kinase, Qik, is a target of the Qin oncogene. (2000) (13)
Tumor Necrosis Factor α and Interleukin 1α Induce Anchorage Independence in v-jun Transgenic Murine Cells (1993) (12)
Oncogenes and the revolution in cancer research: homage to hidesaburo hanafusa (1929-2009). (2010) (12)
Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos. (1992) (12)
Characterization of the transformation-specific sequences of avian erythroblastosis virus in normal vertebrate cells. (1981) (12)
Posttranslational regulation of Myc by promyelocytic leukemia zinc finger protein (2009) (12)
Smooth muscle α-actin is a direct target of PLZF: effects on the cytoskeleton and on susceptibility to oncogenic transformation (2010) (12)
Drug-resistant phosphatidylinositol 3-kinase: guidance for the preemptive strike. (2008) (12)
Avian sarcoma virus PRCII: conditional mutants temperature sensitive in the maintenance of fibroblast transformation. (1981) (12)
THE CELL SURFACE IN TUMOR VIRUS INFECTION. (1963) (12)
Avian oncovirus MH2 is defective in Gag, Pol, and Env. (1979) (11)
The story of Jun. (1995) (10)
The 28 S genomic RNA of avian sarcoma virus PRCII codes for the transformation-specific polyprotein P105. (1981) (10)
Protein expression profiles of C3H 10T1/2 murine fibroblasts and of isogenic cells transformed by the H1047R mutant of phosphoinositide 3-kinase (PI3K) (2011) (10)
Structural similarities of proteins encoded by three classes of avian sarcoma viruses. (1982) (10)
Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide-3-kinase (2011) (10)
Oncogenic transformation by the FOX protein Qin requires DNA binding (2000) (10)
A quail long-term cell culture transformed by a chimeric jun oncogene. (1995) (10)
Avian oncovirus MH2: preferential growth in macrophages and exact size of the genome. (1979) (9)
A random walk in oncogene space: the quest for targets. (1999) (9)
MILESTONES IN BIOLOGICAL RESEARCH Peyton Rous: Homage and Appraisal (1996) (9)
Attenuation of avian reticuloendotheliosis virus: loss of the defective transforming component during serial passage of oncogenic virus in fibroblasts. (1980) (8)
Ts pol mutants of avian sarcoma viruses: mapping and demonstration of single cycle recombinants. (1978) (8)
v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype (2004) (8)
Viral Cytopathology (1984) (8)
Chimeras of herpes simplex viral VP16 and jun are oncogenic. (1993) (8)
The human homologue of the retroviral oncogene qin maps to chromosome 14q13. (1994) (8)
Erratum: The Classic: Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts (1973) (8)
Organization of endogenous and exogenous viral and linked nonviral sequences. (1980) (8)
Integration of avian sarcoma virus specific DNA in mammalian chromatin. (1975) (8)
Immunobiology of Natural Killer Cell Receptors (2006) (8)
Nonproducing State of Rous Sarcoma Cells: Its Contagiousness in Chicken Cell Cultures (1967) (7)
MINCR is not a MYC-induced lncRNA (2016) (7)
Cryo-EM structures of PI3Kα reveal conformational changes during inhibition and activation (2021) (7)
Molecular Medicine in Practice PF-04691502 , a Potent and Selective Oral Inhibitor of PI 3 K and mTOR Kinases with Antitumor Activity (2011) (7)
Use of plastic bags to maintain a humidified atmosphere for animal cell cultures. (1974) (7)
Molecular cloning of the PRCII sarcoma viral genome and the chicken proto-oncogene c-fps. (1985) (6)
Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation (2003) (6)
Genome structure of the defective avian sarcoma virus PRCIV. (1982) (6)
Acute promyelocytic leukemia : molecular genetics, mouse models and targeted therapy (2006) (6)
Synthetic molecules for disruption of the MYC protein-protein interface. (2018) (6)
Two new retroviral onc genes, sea and jun. (1986) (6)
Jun: A transcription factor becomes oncogenic (1992) (6)
An endogenous virus from Lophortyx quail is the prototype for envelope subgroup 1 of avian retroviruses. (1985) (6)
Intradermal Immunization (2012) (5)
DNA methylation and cancer/ edited by P. A. Jones and P. K. Vogt (2000) (5)
ts Transformation mutants of avian sarcoma virus PRCII: lack of strict correlation between transforming ability and properties of the P105-associated kinase. (1983) (5)
A butterfly effect in cancer (2016) (5)
Akt Demoted in Glioblastoma (2009) (5)
Nuclear Export of Viral RNAs (2001) (5)
Endogenous factors that limit seed germination of Acacia senegal Willd (1995) (5)
A humble chicken virus that changed biology and medicine. (2009) (5)
CD4+CD25+ regulatory T cells : origin, function and therapeutic potential (2005) (5)
Oncogenes and Retroviruses (1989) (5)
A temperature-sensitive lesion affecting levels of transformation-specific viral RNA in a mutant of avian sarcoma virus PRCII. (1982) (5)
Cooperative and antagonistic interactions among RNA tumor viruses. (1968) (5)
The C-terminal region of cellular Qin oligomerizes: correlation with oncogenic transformation and transcriptional repression (2003) (4)
The Classic: Integration of Deoxyribonucleic Acid Specific for Rous Sarcoma Virus after Infection of Permissive and Nonpermissive Hosts (2008) (4)
The genetics of jun. (1990) (4)
Biochemical and biological characterization of tumor-associated mutations of p110alpha. (2008) (4)
[The immunology of liver microsomes. I. The properties of the quantitative precipitin system]. (1960) (4)
Growth-related alterations induced in chick embryo fibroblasts by src-gene deletion mutants of the Schmidt-Ruppin strain of Rous sarcoma virus. (1980) (4)
Tumor necrosis factor alpha and interleukin 1 alpha induce anchorage independence in v-jun transgenic murine cells. (1993) (4)
Onc genes and signals of cell growth. (1987) (3)
Relationship between initiating dose and concentration of Rous sarcoma virus (type O) in tumors of germfree quail. (1971) (3)
GENETIC VARIATION AND HOST MARKERS IN THE src GENE OF RECOVERED AVIAN SARCOMA VIRUSES * (1980) (3)
The oncogenicity of Jun. (1992) (3)
Integration of different sarcoma virus genomes into host DNA: evidence against tandem arrangement and for shared integration sites. (1979) (3)
ENDOGENOUS LEUKOSIS VIRUSES OF PHEASANTS (1974) (3)
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer (2013) (3)
[The immunology of liver microsomes. III. The localization of tissue-specific antigens within the structural components of endoplastic reticulum]. (1960) (3)
PRCII, a representative of a new class of avian sarcoma viruses. (1981) (3)
Abstract 3339: The regulatory subunit of PI3K, p85β, induces cellular transformation, enhanced cell proliferation and increased PI3K signaling (2014) (2)
A nonconditional replication-defective mutant of the Schmidt-Ruppin strain of Rous sarcoma virus. (1979) (2)
Phosphatidylinositol 3-kinase (PI3K): The Oncoprotein (2010) (2)
Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα. (2022) (2)
A brave new MYC-amplified world (2015) (2)
The hybrid PAX 3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture ( pediatric rhabdomyosarcoma / PAX protein / winged helix protein / oncogenic transformation / chicken embryo fibroblasts ) (2005) (2)
Oncogenes and retroviruses : selected reviews (1989) (2)
Environmental factors that influence germination of seeds of A. senegal, Willd (1995) (2)
Abstract B136: CAL‐120, a novel dual p110β/p110δ phosphatidylinositol‐3‐kinase (PI3K) inhibitor, attenuates PI3K signaling and demonstrates potent in vivo antitumor activity against solid tumors (2009) (2)
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. (2012) (2)
HETEROLOGOUS TUMOUR GROWTH PATTERNS INDUCED IN RELATED MHC ‐ DEFINED CHICKEN LINES BY SEPARATE ISOLATES OF AN AVIAN SARCOMA VIRUS STRAIN (1981) (2)
Human T-cell leukemia/lymphoma viruses--an introduction. (1985) (2)
Characteristics of three new avian sarcoma viruses, ASV 9, ASV 17, and ASV 25. (1984) (1)
ONCOGENES AND PROTO-ONCOGENES | jun Oncogenes (2006) (1)
Cloned DNA of defective avian sarcoma virus mutant LA46 encodes the cis-acting temperature-sensitive defect in replication. (1985) (1)
JMM and medical science, past and present (2000) (1)
[Viral etiology of human tumors]. (1973) (1)
GelElectrophoresis ofAvianLeukosis and Sarcoma Viral RNA inFormamide: Comparison withOtherViral andCellular RNA Species (1973) (1)
Comprar Phosphoinositide 3-Kinase In Health And Disease (Current Topics In Microbiology And Immunology, Vol. 346) | Vogt, Peter K. | 9783642136627 | Springer (2010) (1)
Anatomy of the RNA and gene products of MC29 and MH2, two defective avian tumor viruses causing acute leukemia and carcinoma: evidence for a new class of transforming genes. (1979) (1)
Proceedings: Genetics and the cancer cell: cell genetics and growth of endogenous viruses. (1972) (1)
Genes and Viruses Able to Transform Hematopoietic Cells Group Report (1985) (1)
Nanobodies and chemical cross-links advance the structural and functional analysis of PI3Kα (2022) (1)
Comprar Phosphoinositide 3-kinase in Health and Disease | Rommel, Christian | 9783642148156 | Springer (2011) (1)
Acute Promyelocytic Leukemia (2007) (1)
Host resistance and the biological analysis of avian tumor virus infections. (1969) (1)
An Algorithm for Generating Small RNAs Capable of Epigenetically Modulating Transcriptional Gene Silencing and Activation in Human Cells (2014) (1)
Cryo-EM Structure of p110alpha in complex with p85alpha (2021) (1)
RECOMBINANTS OF AVIAN RNA TUMOR VIRUSES: CHARACTERISTICS OF THE VIRION RNA (1974) (1)
Cryo-EM structure of p110alpha in complex with p85alpha inhibited by BYL-719 (2021) (1)
Retroviruses 1 (1983) (1)
Use of Plastic Bags to Maintain a Humidified Atmosphere for Animal Cell Cultures (1974) (1)
Abstract A28: Butterfly effect in cancer: How a PI3-kinase mutation remodels the cell (2015) (1)
THE SEVENTEENTH INTERNATIONAL SYMPOSIUM OF THE PRINCESS TAKAMATSU CANCER RESEARCH FUND: ONCOGENES AND CANCER (1987) (1)
The Importance of Being Non-Defective: A Mini Review Dedicated to the Memory of Jan Svoboda (2019) (1)
On the biochemistry of transformation by Rous sarcoma virus. (1980) (1)
Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay. (2021) (1)
[Manifestation of vitamin B1 deficiency in epidemic hepatitis]. (1957) (0)
From Viruses to Genes to Cells. (2019) (0)
Transforming proteins of DNA tumor viruses (1989) (0)
Mapping RNase T -Resistant Oligonucleotides of Avian Tumor (2003) (0)
Welcome to This First Issue of the European Burn Journal (2020) (0)
Mouse Mammary Tumor Virus (2011) (0)
[The immunology of liver microsomes. II. Immunological relations of the microsomes to other cell fractions]. (1960) (0)
Oncogenicity ofAvianLeukosis Viruses ofDifferent Subgroups andofMutants ofSarcoma Viruses (1977) (0)
Crosstalk at La Bretesche. (1994) (0)
AKT Genes, Human (2002) (0)
Abstract 965: Identification of KJ-Pyr-9 as a potent MYC inhibitor (2015) (0)
in \-jun Transgenic Murine Cells1 (2006) (0)
Abstract 2520: Novel inhibitors of β-catenin (2014) (0)
Abstract B14: Anti-miR-135b in colon cancer treatment (2012) (0)
Abstract 5249: Butterfly effect in cancer: How a single base mutation of PIK3CA remodels multiple pathways (2014) (0)
Leukemogenicity of avian oncovirus S13. (1985) (0)
Myogenic signaling of phosphatid serine-threonine kinase Akt/prot (muscle-specific proteins/protein phosphorylation/transdomina) (2016) (0)
Abstract 4479: PF-04691502, a potent and selective PI3K/mTOR dual inhibitor with antitumor activity (2010) (0)
Vinculin distribution and tyrosine phosphorylation in transformed chick embryo fibroblasts (1984) (0)
Oncogenes : selected reviews (1989) (0)
The 60-70S RNA of avian sarcoma and leukosis viruses--distribution of class a and b subunits. (1973) (0)
Retroviruses. Strategies of replication: Preface (1990) (0)
Cancer genes. (1993) (0)
A LAUDATIO FOR DR. YOHEI ITO (1923-1985) (1985) (0)
Regulation differentielle de l'expression genique dans une transformation oncogene (2000) (0)
The orphan receptor tyrosine kinase Ror1 mediates canonical Wnt signaling and is required for NSCLC cell survival in vitro and in vivo. (2008) (0)
Action of Rhodoquine (F. 915) and Quinaorine (R. P. 866) on P. falciparum. (1934) (0)
Comprehensive Virology (1980) (0)
Proposal forNumbering Mutants ofAvianLeukosis and SarcomaViruses (1974) (0)
Oncogenic Transformation by Jun (2017) (0)
Current Topics in Microbiology and Immunology 129 (1986) (0)
Closing remarks for the 20th International Symposium of the Princess Takamatsu Cancer Research Fund. (1990) (0)
Letter from Peter K. Vogt, University of Southern California School of Medicine to Harold Varmus (1975) (0)
Current Topics in Microbiology and Immunology (1977) (0)
Protein synthesis and cancer. (2004) (0)
Current Topics in Microbiology and Immunology (1971) (0)
Retroviruses 3 (1984) (0)
Homology between theDNA-binding domainoftheGCN4 regulatory protein ofyeast andthecarboxyl-termina l region ofaprotein codedforbytheoncogene jun (2011) (0)
Comprar RNA Interference | Paddison, Patrick J. | 9783540751564 | Springer (2008) (0)
Recent and forthcoming publications in pss: Phys. Status Solidi RRL 5/2015 (2015) (0)
Advances in Brief The Oncogeneqin Codesfor a TranscriptionalRepressor ' (2006) (0)
Site of integration of oncogenic viruses in mammalian chromatin. Abstr. (1974) (0)
A Genetic Analysis of PAX 3-FKHR , the Oncogene of Alveolar Rhabdomyosarcoma 1 (1999) (0)
Fourth Annual Sapporo Cancer Seminar Viral Transforming Genes and Oncogenes—Origin, Structure, and Function (1985) (0)
Nonproducing State ofRousSarcomaCells: ItsContagiousness inChicken CellCultures (1967) (0)
Abstract A23: Identification of KJ-Pyr-9 as a potent MYC inhibitor (2015) (0)
Introduction for Harald zur Hausen (1987) (0)
Genetic Mapping of Antibiotic Resistance in Markers Bacillus subtilis* (0)
Nadine Dannemann, Jonathan Ross Hart, Lynn Ueno, and Peter K. Vogt. Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic. Int. J. Cancer 2010; 239―244 (2012) (0)
Current Topics in Microbiology and Immunology (1972) (0)
Publisher Correction: Stereo- and regiodefined DNA-encoded chemical libraries enable efficient tumour-targeting applications (2021) (0)
A Small Molecule RAS-Mimetic Disrupts RAS Associationwith Effector Proteins to Block Signaling Graphical (0)
The first family of oncogenes: appreciation of a Japanese contribution. (1991) (0)
Phosphatidylinositol 3-Kinase Signaling Controls Levels of Hypoxia-inducible Factor 11 (2001) (0)
RNA tumor virus genetics 1975. (1976) (0)
Abstract LB-139: Efficacy, safety, and changes in blood markers following sunitinib monotherapy in patients with advanced hepatocellular carcinoma: Experience from a multidisciplinary Phase II study (2008) (0)
Charles S. Mott Prize. Jun: a transcription factor becomes oncogenic. (1992) (0)
The oncogenicity of jun. (1989) (0)
[The red thread: oncogenes and their convergence in cancer research]. (1985) (0)
The MYC-regulated lncRNA LNROP (ENSG00000254887) enables MYC-driven cell proliferation by controlling the expression of OCT2 (2023) (0)
Abstract 671: Cryo-electronmicroscopy of PI3K reveals additional regulatory features (2022) (0)
Structures of unintegrated and integrated forms of the deoxyribonucleic acid of ribonucleic acid tumour viruses. (1979) (0)
Abstract 1535: Novel lncRNA ENSG00000254887 is a key factor for MYC-driven cell proliferation (2022) (0)
RICHARD BING: 12 OCTOBER 1909 - 8 NOVEMBER 2010. (2014) (0)
Determination of the Leaf Area Index using radiance measurements (1995) (0)
Rhodoquine Fourneau 915. (0)
A Symptom of Lack of Vitamin B1 in Epidemic Hepatitis. (1957) (0)
The Treatment of Malignant Tertian with Rhodoquine U (Fourneau 915). (0)
VIRAL INDUCTION OF NEOPLASMS (0)

This paper list is powered by the following services:

Other Resources About Peter K. Vogt

en.wikipedia.org

What Schools Are Affiliated With Peter K. Vogt?

Peter K. Vogt is affiliated with the following schools:

Peter K. Vogt's Academic­Influence.com Rankings

Peter K. Vogt's Degrees

Why Is Peter K. Vogt Influential?

Peter K. Vogt's Published Works

Published Works

Other Resources About Peter K. Vogt

What Schools Are Affiliated With Peter K. Vogt?

Peter K. Vogt's AcademicInfluence.com Rankings